These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34740082)

  • 1. A systematic literature review and meta-analysis on the impact of COPD on atrial fibrillation patient outcome.
    Ye J; Yao P; Shi X; Yu X
    Heart Lung; 2022; 51():67-74. PubMed ID: 34740082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and prognostic significance of chronic obstructive pulmonary disease in patients with atrial fibrillation: results from a multicenter atrial fibrillation registry study.
    Huang B; Yang Y; Zhu J; Liang Y; Zhang H; Tian L; Shao X; Wang J
    J Am Med Dir Assoc; 2014 Aug; 15(8):576-81. PubMed ID: 24894999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients.
    Romiti GF; Corica B; Pipitone E; Vitolo M; Raparelli V; Basili S; Boriani G; Harari S; Lip GYH; Proietti M;
    Eur Heart J; 2021 Sep; 42(35):3541-3554. PubMed ID: 34333599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
    Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
    Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detrimental Impact of Chronic Obstructive Pulmonary Disease in Atrial Fibrillation: New Insights from Umbria Atrial Fibrillation Registry.
    Angeli F; Reboldi G; Trapasso M; Aita A; Ambrosio G; Verdecchia P
    Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31324041
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of chronic obstructive pulmonary disease in patients with atrial fibrillation: an analysis from the GLORIA-AF registry.
    Romiti GF; Corica B; Mei DA; Frost F; Bisson A; Boriani G; Bucci T; Olshansky B; Chao TF; Huisman MV; Proietti M; Lip GYH
    Europace; 2023 Dec; 26(1):. PubMed ID: 38266129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation.
    Durheim MT; Holmes DN; Blanco RG; Allen LA; Chan PS; Freeman JV; Fonarow GC; Go AS; Hylek EM; Mahaffey KW; Pokorney SD; Reiffel JA; Singer DE; Peterson ED; Piccini JP
    Heart; 2018 Nov; 104(22):1850-1858. PubMed ID: 29875139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Augmentation of the Risk of Ischemic Cerebrovascular Accident by Chronic Obstructive Pulmonary Disease in Patients with Atrial Fibrillation.
    Nadeem R; Sharieff A; Tanna S; Sidhu H; Molnar J; Nadeem A
    J Stroke Cerebrovasc Dis; 2015 Aug; 24(8):1893-6. PubMed ID: 26142261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of atrial fibrillation, stroke, and death after radiofrequency catheter ablation of typical atrial flutter.
    Seara JG; Roubin SR; Gude Sampedro F; Barreiro VB; Sande JM; Mañero MR; Grandio PC; Alvarez B; Juanatey JG
    Clin Res Cardiol; 2014 Jul; 103(7):543-52. PubMed ID: 24566731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Death and Cardiovascular Events in Asian Patients With Atrial Fibrillation and Chronic Obstructive Pulmonary Disease: A Report From the Prospective APHRS Registry.
    Bucci T; Romiti GF; Shantsila A; Teo WS; Park HW; Shimizu W; Corica B; Proietti M; Tse HF; Chao TF; Frost F; Lip GYH;
    J Am Heart Assoc; 2024 Apr; 13(7):e032785. PubMed ID: 38533983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study.
    Raparelli V; Pastori D; Pignataro SF; Vestri AR; Pignatelli P; Cangemi R; Proietti M; Davì G; Hiatt WR; Lip GYH; Corazza GR; Perticone F; Violi F; Basili S;
    Intern Emerg Med; 2018 Aug; 13(5):651-660. PubMed ID: 29582316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHA2DS2-VASc score for ischaemic stroke risk stratification in patients with chronic obstructive pulmonary disease with and without atrial fibrillation: a nationwide cohort study.
    Hu WS; Lin CL
    Europace; 2018 Apr; 20(4):575-581. PubMed ID: 28407109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of atrial fibrillation on cardiac prognosis in chronic obstructive pulmonary disease.
    Tomioka T; Fukui K; Tanaka S; Ito Y; Shioiri H; Koyama J; Inoue K
    Indian Heart J; 2019; 71(1):7-11. PubMed ID: 31000186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation and chronic obstructive pulmonary disease: diagnostic sequence and mortality risk.
    Warming PE; Garcia R; Hansen CJ; Simons SO; Torp-Pedersen C; Linz D; Tfelt-Hansen J
    Eur Heart J Qual Care Clin Outcomes; 2023 Feb; 9(2):128-134. PubMed ID: 36069895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of the clinical outcomes and prognosis associated with comorbid COPD in the atrial fibrillation population.
    Rodríguez-Mañero M; López-Pardo E; Cordero A; Ruano-Ravina A; Novo-Platas J; Pereira-Vázquez M; Martínez-Gómez Á; García-Seara J; Martínez-Sande JL; Peña-Gil C; Mazón P; García-Acuña JM; Valdés-Cuadrado L; González-Juanatey JR
    Int J Chron Obstruct Pulmon Dis; 2019; 14():371-380. PubMed ID: 30863038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The increased risk of atrial fibrillation in inflammatory arthritis: a systematic review and meta-analysis of cohort studies.
    Ma Y; Pan Z; Fan D; Xu S; Pan F
    Immunol Invest; 2022 May; 51(4):1095-1107. PubMed ID: 33563055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
    Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
    Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competitive interaction between chronic obstructive pulmonary disease and CHA
    Perticone M; Sciacqua A; Tripepi G; Miceli S; Corrao S; Sesti G; Perticone F
    Int J Cardiol; 2018 Mar; 255():74-79. PubMed ID: 29174184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral artery disease and clinical outcomes in patients with atrial fibrillation: A systematic review and meta-analysis.
    Zhu J; Tan X; Zhou JZ
    Clin Cardiol; 2021 Aug; 44(8):1050-1057. PubMed ID: 34170015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-blockers reduce severe exacerbation in patients with mild chronic obstructive pulmonary disease with atrial fibrillation: a population-based cohort study.
    Lin SJ; Liao XM; Chen NY; Chang YC; Cheng CL
    BMJ Open Respir Res; 2023 Nov; 10(1):. PubMed ID: 37989489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.